Show&Tell #2: Medulloblastoma
Dr Torunn Yock, Director of Pediatric Radiation Oncology, will share the main lessons...
Dr Torunn Yock, Director of Pediatric Radiation Oncology, will share the main lessons...
This study compared the carcinogenic risk associated with 3D-CRT, IMAT and PBS-PT)in the treatment of pediatric abdominal neuroblastoma. The risk of radiation...
Proton beam therapy is accepted as a preferred radiation modality in pediatric cancers to minimize the late radiation side effects. This review compared the...
Neurocognitive outcomes were evaluated in 103 pediatric brain tumor patients (proton RT n = 26, photon RT n = 30, surgery n = 47) before and after treatment...
A review on proton therapy situation in the UK. Since the first proton therapy center opening in Manchester in 2018, by September 2019, 108 patients had started...
This study by the University of Florida, Jacksonville, reviewed 25 patients (≤21 years old) with nonmetastatic Ewing sarcoma of the cranium and skull base...
Published in the Journal of Clinical Oncology, this multi-center study compared the intellectual trajectories between pediatric patients treated for...
Fifty-nine brain tumor children < 4 years old received PRT were followed for the median 9.1 years (5.5-18 years). The report of long-term health related quality...
This systematic review provides latest outcomes data after proton therapy across the common pediatric disease sites.
It discusses the main attempts to assess...